Amerigon Reports 2009 Second Quarter, Six-Month Results

Aug 5, 2009
NORTHVILLE, Mich., Aug 05, 2009 /PRNewswire-FirstCall via COMTEX/ -- Amerigon Incorporated (Nasdaq: ARGN), a leader in developing and marketing products based on advanced thermoelectric (TE) technologies, today announced results for this year's second quarter and first six months ended June 30, 2009.

Product revenues as previously disclosed were relatively flat for the 2009 second quarter at $10.7 million, compared with $10.2 million for the 2009 first quarter. Year-over-year, this compares with $16.8 million for the second quarter of last year. The decline in product revenue was due to lower sales of existing vehicles offering the Company's Climate Control Seat(R) (CCS(R)) system, partially offset by higher sales from the introduction of a number of new vehicle models offering CCS subsequent to last year's second quarter. The lower sales of existing vehicles reflected a significant decline in the overall automotive market.

Automotive sales volumes, impacted by the decline in worldwide economic activity and the limited availability of consumer credit, were significantly lower during this year's second quarter compared with the year-earlier period. In North America, one of the Company's most important markets, the Seasonally Adjusted Annual Rate ("SAAR") for vehicle sales decreased 32 percent to 9.6 million from 14.1 million during the second quarter of 2008. Vehicle production levels have been reduced accordingly.

President and Chief Executive Officer Daniel R. Coker said the acceptance of the CCS system by the automotive industry and car buyers remains strong. Even though automotive sales volumes are down dramatically due to the global recession, Amerigon continues to add new vehicles offering its heated and cooled and heated and ventilated seat systems and consumer take rates of those systems remain strong.

"While we expected similar results in the second quarter sequentially from the first due to customer production levels, we are more optimistic about the second half of the year," said President and Chief Executive Officer Daniel R. Coker. "Despite the current turmoil in the global automotive industry, we continue to make significant progress. We are very excited about working with Kia, a very well respected brand known throughout the world. And we believe our new venture in the automotive aftermarket is the start of a very successful partnership. Overall, our objective is to continue to enter new markets that will diversify us from automotive seats and, ultimately, to emerge as a stronger company as the economy recovers."

Gross margin as a percentage of revenue for the 2009 second quarter was 24 percent compared with 31 percent in the 2008 second quarter. The year-over-year decrease was primarily attributable to higher raw material costs, especially Tellurium, a key component of CCS, a change in the mix of products sold toward programs having a lower gross margin percentage, and lower coverage of fixed cost at the lower volume levels. Net loss for second quarter 2009 was $869,000, or $0.04 loss per share, compared with net income in last year's second quarter of $1.3 million, or $0.06 per share.

For the first six months of 2009, revenues were $20.9 million, compared with $34.2 million for the year-earlier period. Gross margin as a percentage of revenue for this year's first six months was 24 percent compared with 32 percent in the first six months of last year. For the first six months of 2009, net loss was $1.8 million, or $0.08 loss per share, compared to net income of $2.6 million, or $0.12 per share for the prior year period.

The highlights of the 2009 second quarter included the introduction of several new vehicle models featuring Amerigon's seat systems, including the first ever Kia vehicles, and the launch of the Amerigon heated and cooled and heated and ventilated seat systems in the automotive aftermarket in partnership with Austin, TX-based Classic Soft Trim. CCS is currently offered as an optional feature on 41 automobile models produced by Ford, General Motors, Toyota, Nissan, Honda and Hyundai. Tata Motors features CCS on its Jaguar and Land Rover luxury vehicles which it acquired from Ford in 2008.

The Company's balance sheet as of June 30, 2009 remained strong with cash and cash equivalents totaling $26.2 million, total assets of $53.7 million, no bank debt and shareholders' equity of $44.9 million.

Coker added that Amerigon's proprietary TE technology continues to show potential for product development outside the automotive industry. Based on research and development performed by its BSST subsidiary, Amerigon is pursuing heating and cooling applications in such markets as consumer goods, computers, commercial heating and air conditioning, and the military. The Company, along with several commercial and academic partners, is also focused on the recovery of waste heat to generate electricity.

"In the near term, the majority of our revenue will continue to come from the automotive industry but we are more confident than ever that our future lies in a much broader, diverse product line," Coker said. "Our work with present and potential commercial partners demonstrates that there are major markets that are very conducive to the potential of our thermoelectric technology."

New vehicles equipped with CCS and launched since the end of the second quarter 2008 included the Lincoln MKT, Ford F150 Pickup, Chevrolet Suburban, Chevrolet Tahoe, Chevrolet Avalanche, GMC Yukon, GMC Yukon XL, GMC Yukon Denali, GMC Sierra Pickup, Jaguar XK, Toyota Crown Majesta and Infiniti G Convertible. One program, the Nissan Maxima, launched during 2008 had higher revenue in 2009 due to the impact of full quarter shipments.

Unit shipments of CCS systems for the 2009 second quarter and first six months were 154,000 and 297,000, respectively, compared with 253,000 and 506,000 units for the respective year-earlier periods, again due largely to a significant decline in the overall automotive market.

This year's second quarter and six-month results include year-over-year increases in net research and development expenses of $77,000 and $233,000, respectively, due to increased research activities associated with the Company's advanced TE program partially offset by lower costs to support a smaller number of new vehicle programs to be launched during 2009 compared to 2008. The increase in research and development expenses in the advanced TE program is associated with a recent breakthrough in the development of significantly more efficient TE materials.

Coker said, "We remain very excited about the long term future of Amerigon and the potential of our proprietary thermoelectric technology. The global focus on energy efficiencies, on electric, plug-in and hybrid vehicles, and a more environmentally friendly approach by business in general works in tandem with our own internal efforts and strategic focus. It is our intent to establish new products and new markets and prepare to expand in the future as the global economy recovers."

Guidance

Due to the most recent news in the marketplace with respect to customer production levels, the Company expects revenues to increase 30 to 40 percent for the third quarter compared with the 2009 first and second quarters. The current uncertainty in the global automotive market and the resulting lack of visibility make it difficult for Amerigon to provide meaningful fourth quarter and, therefore, full-year financial guidance for 2009.

Conference Call

As previously announced, Amerigon is conducting a conference call today to be broadcast live over the Internet at 11:30 AM Eastern Time to review the financial results for the second quarter and six months ended June 30, 2009. The dial-in number for the call is 1-877-941-1469. The live webcast and archived replay of the call can be accessed in the Events page of the Investor section of Amerigon's website at www.amerigon.com.

About Amerigon

Amerigon (Nasdaq: ARGN) develops products based on its advanced, proprietary, efficient thermoelectric (TE) technologies for a wide range of global markets and heating and cooling applications. The Company's current principal product is its proprietary Climate Control Seat(R) (CCS(R)) system, a solid-state, TE-based system that permits drivers and passengers of vehicles to individually and actively control the heating and cooling of their respective seats to ensure maximum year-round comfort. CCS, which is the only system of its type on the market today, uses no CFCs or other environmentally sensitive coolants. Amerigon maintains sales and technical support centers in Southern California, Detroit, Japan, Germany, England and Korea.

Certain matters discussed in this release are forward-looking statements that involve risks and uncertainties, and actual results may be different. Important factors that could cause the Company's actual results to differ materially from its expectations in this release are risks that sales may not significantly increase, additional financing, if necessary, may not be available, new competitors may arise and adverse conditions in the automotive industry may negatively affect its results. The liquidity and trading price of its common stock may be negatively affected by these and other factors. Please also refer to Amerigon's Securities and Exchange Commission filings and reports, including, but not limited to, its Form 10-Q for the period ended June 30, 2009, and its Form 10-K for the year ended December 31, 2008.

    Contact:    Allen & Caron Inc
                Jill Bertotti (investors)
                jill@allencaron.com
                Len Hall (media)
                len@allencaron.com
                (949) 474-4300

                                TABLES FOLLOW



                              AMERIGON INCORPORATED

                 CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
                        (In thousands, except per share data)
                                      (Unaudited)

                                    Three Months Ended   Six Months Ended
                                          June 30,             June 30,
                                    ------------------   -----------------
                                       2009      2008      2009      2008
                                    --------   -------   -------   -------
    Product revenues                 $10,715   $16,796   $20,885   $34,156
    Cost of sales                      8,184    11,517    15,936    23,318
                                       -----    ------    ------    ------
      Gross margin                     2,531     5,279     4,949    10,838
    Operating expenses:
      Research and development         1,919     2,183     4,338     4,582
      Research and development
       reimbursements                   (345)     (686)   (1,018)   (1,495)
                                         ---       ---     -----     -----
        Net research and development
         expenses                      1,574     1,497     3,320     3,087
      Selling, general and
       administrative                  2,166     2,032     4,315     4,159
                                       -----     -----     -----     -----
        Total operating expenses       3,740     3,529     7,635     7,246
                                       -----     -----     -----     -----
    Operating income (loss)           (1,209)    1,750    (2,686)    3,592
    Interest income                        4       218        26       515
    Other income                          45        35        97        87
                                         ---       ---       ---       ---
    Earnings (loss) before income
     tax                              (1,160)    2,003    (2,563)    4,194
    Income tax expense (benefit)        (291)      749      (758)    1,569
                                         ---       ---       ---     -----
    Net income (loss)                  $(869)   $1,254   $(1,805)   $2,625
                                       =====    ======   =======    ======
    Basic earnings (loss)
     per share                        $(0.04)    $0.06    $(0.08)    $0.12
                                      ======     =====    ======     =====
    Diluted earnings (loss)
     per share                        $(0.04)    $0.06    $(0.08)    $0.12
                                      ======     =====    ======     =====
    Weighted average number of
     shares - basic                   21,420    22,140    21,327    22,072
                                      ======    ======    ======    ======
    Weighted average number of
     shares - diluted                 21,420    22,710    21,327    22,759
                                      ======    ======    ======    ======




                                AMERIGON INCORPORATED

                       CONSOLIDATED CONDENSED BALANCE SHEETS
                           (In thousands, except share data)

                                                June 30,       December 31,
                                                  2009              2008
                                               ----------      ------------
                                              (unaudited)
    ASSETS

    Current Assets:
      Cash & cash equivalents                   $26,167           $25,303
      Accounts receivable, less allowance
       of $261 and $318, respectively             6,807             8,292
      Inventory:
        Raw materials                               140               189
        Finished goods                            3,337             2,452
                                                  -----             -----
            Inventory                             3,477             2,641
      Deferred income tax assets                    956               986
      Prepaid expenses and other assets             511               417
                                                    ---               ---
          Total current assets                   37,918            37,639
    Property and equipment, net                   3,934             4,274
    Patent costs, net of accumulated
     amortization of $392 and $298,
     respectively                                 3,522             3,156
    Deferred income tax assets                    8,141             7,334
    Other non-current assets                        195               196
                                                    ---               ---
          Total assets                          $53,710           $52,599
                                                =======           =======

    LIABILITIES AND SHAREHOLDERS' EQUITY

    Current Liabilities:
      Accounts payable                           $5,381            $3,872
      Accrued liabilities                         2,835             3,096
      Deferred manufacturing
       agreement - current portion                  200               200
                                                    ---               ---
          Total current liabilities               8,416             7,168
    Pension Benefit Obligation                      236               142
    Deferred manufacturing
     agreement - long-term portion                  150               250
                                                    ---               ---
          Total liabilities                       8,802             7,560
    Shareholders' equity:
      Common Stock:
        No par value; 30,000,000 shares
         authorized, 21,467,492 and
         21,205,492 issued and outstanding at
         June 30, 2009 and December 31, 2008,
         respectively                            61,822            60,727
      Paid-in capital                            23,327            22,720
      Accumulated other comprehensive
       income - foreign currency                     69                97
      Accumulated deficit                       (40,310)          (38,505)
                                                 ------            ------
        Total shareholders' equity               44,908            45,039
                                                 ------            ------
        Total liabilities and
         shareholders' equity                   $53,710           $52,599
                                                =======           =======




                             AMERIGON INCORPORATED

               CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
                           (In thousands, unaudited)

                                                    Six Months Ended
                                                         June 30,
                                               --------------------------
                                                  2009             2008
                                               --------          --------
    Operating Activities:
      Net income (loss)                         $(1,805)           $2,625
      Adjustments to reconcile net income
       (loss) to cash provided by operating
       activities:
        Depreciation and amortization               704               625
        Deferred tax provision (benefit)           (777)            1,431
        Stock option compensation                   607               435
        Defined benefit plan expense                 95                 -
        Loss on disposal of property and equipment    -                10
        Changes in operating assets and
         liabilities:
          Accounts receivable                     1,485               389
          Inventory                                (836)           (2,617)
          Prepaid expenses and other assets         (94)               16
          Accounts payable                        1,508              (401)
          Accrued liabilities                        37              (413)
                                                    ---               ---
        Net cash provided by operating activities   924             2,100

    Investing Activities:
      Purchases of investments                        -            (3,100)
      Sales and maturities of investments             -            14,000
      Purchase of property and equipment           (369)           (1,247)
      Patent costs                                 (459)             (261)
                                                    ---               ---
        Net cash (used in) provided by
         investing activities                      (828)            9,392

    Financing Activities:
      Proceeds from the exercise of Common
       Stock options                                796               940
                                                    ---               ---
        Net cash provided by financing activities   796               940
                                                    ---               ---

        Foreign currency effect                     (28)                7
                                                    ---               ---
        Net increase in cash and cash
         equivalents                                864            12,439
        Cash and cash equivalents at beginning
         of period                               25,303             1,170
                                                 ------             -----
        Cash and cash equivalents at end
         of period                              $26,167           $13,609
                                                =======           =======
    Supplemental disclosure of cash flow
     information:
      Cash paid for taxes                          $298              $172
                                                   ====              ====
    Supplemental disclosure of non-cash
     transactions:
      Issuance of Common Stock under the
       2006 Equity Incentive Plan                  $299              $344
                                                   ====              ====


SOURCE Amerigon Incorporated


http://www.amerigon.com